CN1768769A - Wart resistor - Google Patents
Wart resistor Download PDFInfo
- Publication number
- CN1768769A CN1768769A CN 200510010358 CN200510010358A CN1768769A CN 1768769 A CN1768769 A CN 1768769A CN 200510010358 CN200510010358 CN 200510010358 CN 200510010358 A CN200510010358 A CN 200510010358A CN 1768769 A CN1768769 A CN 1768769A
- Authority
- CN
- China
- Prior art keywords
- wart
- powder
- gram
- dawn
- duck
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000010153 skin papilloma Diseases 0.000 title claims abstract description 25
- 208000000260 Warts Diseases 0.000 title claims abstract description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000000843 powder Substances 0.000 claims abstract description 14
- 239000003814 drug Substances 0.000 claims abstract description 10
- HBGOLJKPSFNJSD-UHFFFAOYSA-N Etamsylate Chemical compound CC[NH2+]CC.OC1=CC=C(O)C(S([O-])(=O)=O)=C1 HBGOLJKPSFNJSD-UHFFFAOYSA-N 0.000 claims abstract description 7
- 241000272525 Anas platyrhynchos Species 0.000 claims description 8
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 8
- 229940079593 drug Drugs 0.000 claims description 7
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 claims description 6
- 229960004817 etamsylate Drugs 0.000 claims description 6
- 229960004194 lidocaine Drugs 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 3
- 241000208225 Rhus Species 0.000 abstract 1
- 235000014220 Rhus chinensis Nutrition 0.000 abstract 1
- 235000019441 ethanol Nutrition 0.000 description 7
- 206010059313 Anogenital warts Diseases 0.000 description 4
- 241000934136 Verruca Species 0.000 description 4
- 201000004196 common wart Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 241001517488 Clavus Species 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 2
- 208000029742 colonic neoplasm Diseases 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- 208000008710 Amebic Dysentery Diseases 0.000 description 1
- 206010001986 Amoebic dysentery Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- 210000000589 cicatrix Anatomy 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000002647 laser therapy Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 208000028173 post-traumatic stress disease Diseases 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a wart-removing medicament, which comprises (by weight ratio) 10% false sumac oil, 1% fastocaine powder, 1% dicynone powder and 88% medicinal ethanol.
Description
Technical field
The invention belongs to medical drugs, relate generally to a kind of medicine for the treatment of diseases such as verruca plana, verruca vulgaris, condyloma acuminatum.
Background technology
At present, oral and the injectable drug that is used for the treatment of wart class diseases such as verruca plana, verruca vulgaris, condyloma acuminatum is more, play certain positive role aspect ailing alleviating, but these medicines not only price are more expensive, and in therapeutic process the course of treatment long, reach the several months to the several years, can not thoroughly cure, the relapse rate height is big to the side effect of patient body internal organs.Operation or laser therapy also are current conventional means, but treat the back except that easy recurrence, also very easily leave cicatrix at operative site, even cause local deformation and deformity, bring very big moral injury to the patient.
Summary of the invention
Purpose of the present invention is exactly problem and the defective that exists at above-mentioned prior art, study a kind of gram wart that can effectively treat wart class disease, reaches that therapeutic effect is good, short treating period, cheap, purpose that use is simple.
The object of the present invention is achieved like this: the gram wart is made up of the duck dawn seed oil of Chinese crude drug and the medical ethanol compatibility of lignocaine powder, etamsylate powder and alcohol concentration 95%, is respectively by each composition proportion of its weight: duck dawn seed oil 10%, lignocaine powder 1%, etamsylate powder 1%, medical ethanol 88%.
Gram wart of the present invention is applicable to condyloma acuminatum, verruca plana, verruca vulgaris, clavus, the hands nail that viral infection causes, also can be used for treating the treatment of amebic dysentery, colon cancer, can be at short notice with the deactivation of various viral wart body inner virus, ameba and colon cancer are had certain curative effect, have short treating period, good effect, do not recur, painless, not hemorrhage, preventing from scar, no deformity, need not to be in hospital, simple and convenient is used in treatment, need not any ancillary drug, the characteristics of cheap, wide accommodation.
The specific embodiment
Give an actual example below and be elaborated.
At first Chinese crude drug duck dawn seed oil is shelled with hulling machine, the reuse oil press squeezes duck dawn seed oil.Medical ethanol 880 grams that take by weighing duck dawn seed oil 100 grams, lignocaine powder 10 grams, etamsylate powder 10 grams, alcohol concentration 95% respectively are standby, and its each composition proportion by weight is followed successively by 10%, 1%, 1% and 88%, amounts to 100%; With 100 gram duck dawn seed oils and 10 gram lignocaine powder, 10 gram etamsylate powder and 880 gram medical ethanols uniform mixing in the lump obtain being golden yellow, ethanol is distinguished the flavor of and the gram wart liquid preparation of little hardship, liquid is restrained wart packs into standby in the aseptic exsiccant glass drying oven.
When treatment was used, according to wart body size, injection gram wart 0.1-0.2 milliliter got final product in wart body basilar part partial closure, also can adopt the seton treatment method.In treatment, except that the rubescent and hypodynia sense in part, there is not any other untoward reaction.In the clinical experiment, with gram wart treatment verruca plana, verruca vulgaris patient's 198 examples, condyloma acuminatum patient 6 examples, clavus patient 12 examples are in disposable 7 days and all cure, and no case was recurrence.This medicine can not be oral and be done vein or intramuscular injection is used.
Claims (1)
1, a kind of gram wart, it is characterized in that this gram wart is made up of the duck dawn seed oil of Chinese crude drug and the medical ethanol compatibility of lignocaine powder, etamsylate powder and alcohol concentration 95%, be respectively by each composition proportion of its weight: duck dawn seed oil 10%, lignocaine powder 1%, etamsylate powder 1%, medical ethanol 88%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510010358 CN1768769A (en) | 2005-09-22 | 2005-09-22 | Wart resistor |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510010358 CN1768769A (en) | 2005-09-22 | 2005-09-22 | Wart resistor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1768769A true CN1768769A (en) | 2006-05-10 |
Family
ID=36750474
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200510010358 Pending CN1768769A (en) | 2005-09-22 | 2005-09-22 | Wart resistor |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1768769A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008020037A1 (en) * | 2006-08-16 | 2008-02-21 | Action Medicines, S.L. | Use of 2,5-dihydroxybenzene derivatives for treating obesity, hirsutism, hypertricosis and viral warts |
| ES2315119A1 (en) * | 2006-08-16 | 2009-03-16 | Action Medicines, S.L. | Use of derivatives 2.5 -dihidrocibencenicos in the manufacture of medicines and cosmetics (Machine-translation by Google Translate, not legally binding) |
-
2005
- 2005-09-22 CN CN 200510010358 patent/CN1768769A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008020037A1 (en) * | 2006-08-16 | 2008-02-21 | Action Medicines, S.L. | Use of 2,5-dihydroxybenzene derivatives for treating obesity, hirsutism, hypertricosis and viral warts |
| ES2315119A1 (en) * | 2006-08-16 | 2009-03-16 | Action Medicines, S.L. | Use of derivatives 2.5 -dihidrocibencenicos in the manufacture of medicines and cosmetics (Machine-translation by Google Translate, not legally binding) |
| ES2315119B1 (en) * | 2006-08-16 | 2009-12-30 | Action Medicines, S.L. | USE OF DERIVATIVES 2,5-HYDROXIBENCENICOS IN THE MANUFACTURE OF MEDICINES AND COSMETICS. |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20210008239A1 (en) | Medical Ozone Sterile Isotonic Saline Solution And Preparation Method And Application Thereof | |
| US20040180868A1 (en) | Composition and method for treating inflammations by reducing C-reactive protein | |
| CN1768769A (en) | Wart resistor | |
| CN102302559B (en) | Medicament for treating respiratory system diseases and application thereof | |
| CN102343006A (en) | Ointment for treating burns and scalds, and preparation method thereof | |
| CN102078472A (en) | Medicament for treating verruca wart | |
| CN1488368A (en) | Medicine for treating nasitis | |
| CN100556440C (en) | A kind of traditional Chinese medicine composition for treating diabetes and its preparation method and application | |
| Mavrakakis | IgE-Mediated Cytokine Storm in Vaccinated Populations: Call for Further Investigation and Caution | |
| CN100998604B (en) | Traditional Chinese medicine for treat burns and scald and its preparing method | |
| CN102988403A (en) | Injection medicine composition used for treating facial paralysis in acute stage | |
| CN101837016B (en) | Chinese medicinal preparation for curing trauma | |
| Lockhart | (834): Topical sterile lidocaine patch to reduce postoperative pain and decrease need for oral analgesics after inguinal herniorrhaphy | |
| CN1273161C (en) | Ru'an oral liquor | |
| CN102091187A (en) | Medicinal wine special for treating rheumatoid diseases | |
| Tymofieieva et al. | Usage of the Medical Product Ketanov in the Maxillofacial Surgery | |
| CN100998659A (en) | External use traditional Chinese medicine for treating injury or wound | |
| CN106822234A (en) | It is a kind of to treat Chinese and western medicinal composition of hypertension and preparation method thereof | |
| CN107029189A (en) | Treat the Chinese medicine of coronary heart disease | |
| CN101972296A (en) | External traditional Chinese medicine for treating facial paralysis | |
| CN1868465A (en) | Application of anthraquinone derivatives (emodin) for pharmacy | |
| CN104800241B (en) | Oxygen-enriched drug combination medical technology | |
| CN106619975A (en) | Medicine injected at Zusanli acupoint for treating diabetic foot and preparation method of medicine | |
| CN119700946A (en) | Application of Ryk-Fc fusion protein in preparation of anti-cancer pain drugs | |
| CN102784201B (en) | A kind of caking for the treatment of is without the pasty medicament of head dummy summer boil |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |